UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  July 2, 2010
 
EXACT SCIENCES CORPORATION
(Exact Name of Registrant as Specified in Charter)

Delaware	 	000-32179	 	02-0478229	
(State or Other Jurisdiction
of Incorporation)	 	(Commission
File Number)	 	(I.R.S. Employer
Identification No.)	
 
441 Charmany Drive
Madison, WI  53719
(Address of Principal Executive Offices)(Zip Code)
 
Registrant’s telephone number, including area code:  (608) 284-5700
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o             Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
Item 8.01 Other Events
 
Exact Sciences Corporation (the “Company”) maintains the 1995 Stock Option Plan, the 2000 Stock Option and Incentive Plan and the 2000 Employee Stock Purchase Plan. In the footnotes to the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2009 filed with the Securities and Exchange Commission on March 12, 2010 the Company reported restricted stock and stock option award information on a combined basis.  The following table supplements this information by separately showing restricted stock and stock option awards under these plans for the years ended December 31, 2009, December 31, 2008 and December 31, 2007:

Options and Restricted Stock	 	Options	 	Restricted Stock	 	Total	 	
Outstanding, January 1, 2007	 	4,125,940	 	—	 	4,125,940	 	
Granted	 	1,277,000	 	85,000	 	1,362,000	 	
Exercised	 	(88,237	)	(66,249	)	(154,486	)	
Cancelled	 	(1,336,766	)	—	 	(1,336,766	)	
Outstanding, December 31, 2007	 	3,977,937	 	18,751	 	3,996,688	 	
 	 	 	 	 	 	 	 	
Granted	 	573,600	 	245,000	 	818,600	 	
Exercised	 	(5,979	)	(78,751	)	(84,730	)	
Cancelled	 	(1,026,659	)	—	 	(1,026,659	)	
Outstanding, December 31, 2008	 	3,518,899	 	185,000	 	3,703,899	 	
 	 	 	 	 	 	 	 	
Granted	 	4,859,999	 	411,128	 	5,271,127	 	
Exercised	 	(380,354	)	(510,182	)	(890,536	)	
Cancelled	 	(2,086,525	)	(45,946	)	(2,132,471	)	
Oustanding, December 31, 2009	 	5,912,019	 	40,000	 	5,952,019	 	
 
2 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 	EXACT SCIENCES CORPORATION	
 	 	
Date: July 2, 2010	By:	/s/ Maneesh Arora	
 	 	Maneesh Arora	
 	 	Senior Vice President and Chief Financial Officer	
 
3